Related Experiment Videos

Substrate cleavage by caspases generates protein fragments with Smac/Diablo-like activities

K Hell1, M Saleh, G D Crescenzo

  • 1Merck Research Laboratories, Merck Frosst Centre for Therapeutic Research, PO Box 1005, Pointe Claire-Dorval, Quebec, Canada H9R 4P8.

Insights

New findings reveal that cleaved cell death substrates can mimic Smac/Diablo (SMAC/DIABLO) to inhibit IAP proteins like XIAP, enhancing apoptosis. This mechanism may be relevant in Alzheimer's disease.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Inhibitor of Apoptosis Proteins (IAPs) regulate programmed cell death.
  • Smac/Diablo (SMAC/DIABLO) and HtrA2/Omi antagonize IAPs, promoting apoptosis.
  • X-linked inhibitor of apoptosis (XIAP) is a key IAP target.

Purpose of the Study:

  • To investigate novel mechanisms of IAP antagonism.
  • To explore the role of caspase-mediated cleavage in apoptosis regulation.
  • To examine the relevance of these findings in Alzheimer's disease.

Main Methods:

  • Analysis of caspase-mediated proteolysis of cell death substrates.
  • Biochemical assays to assess binding of cleaved substrates to XIAP.
  • Investigation of the functional consequences of substrate cleavage on apoptosis.

Main Results:

  • Caspase cleavage of specific substrates exposes N-termini with Smac/Diablo-like activity.
  • These cleaved substrates effectively bind and antagonize XIAP.
  • The caspase-generated C31 peptide from Alzheimer's disease exhibits Smac/Diablo-like properties post-cleavage.

Conclusions:

  • A novel feedforward mechanism sensitizes the apoptotic pathway.
  • This process contributes to the functional redundancy of IAP antagonism.
  • The findings suggest a potential role in Alzheimer's disease pathogenesis.

Related Concept Videos